About Index Trending news
Lists
Pricing
EpiTherapeutics

EpiTherapeutics

EpiTherapeutics

EpiTherapeutics is developing novel innovative cancer drugs based on world leading research in epigenetics.

Elsewhere

Alexa global traffic share

Acquired by
06 May 2015
Gilead Sciences
$65,000,000
1
$65,000,000
VentureWire

Gilead to Buy EpiTherapeutics for $65M

Funding